GENEVA, Nov. 10 -- CRISPR THERAPEUTICS AG (Baarerstrasse 14CH-6300 Zug) filed a patent application (PCT/IB2025/000194) for " IN VIVO HEMATOPOIETIC STEM CELL GENE EDITING" on Apr 28, 2025. With publication no. WO/2025/229399, the details related to the patent application was published on Nov 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KALAITZIDIS, Demetrios (610 Main St.Cambridge, MA 02139), TERRETT, Jonathan (610 Main St.Cambridge, MA 02139)

Abstract: The present invention relates to methods for treating diseases by the in vivo gene editing of hematopoietic stem and progenitor cell...